Trial Profile
Pharmacokinetic study of doripenem and meropenem in patients with benign prostatic hypertrophy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Doripenem (Primary) ; Meropenem (Primary)
- Indications Prostatitis
- Focus Pharmacodynamics; Pharmacokinetics
- 18 Dec 2015 New trial record